Life-threatening bronchospasm after intramuscular carboprost for postpartum haemorrhage

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 3, 2007, Pages 366-368

  Harber, C R ^a   Levy, D M ^a   Chidambaram, S ^a   Macpherson, M B ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; CARBOPROST TROMETAMOL; ENOXAPARIN; ERGOMETRINE; HYDROCORTISONE; KETAMINE; MAGNESIUM SULFATE; OXYTOCIN; SALBUTAMOL;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BRONCHOSPASM; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; COLLOID; CRYSTALLOID; ERYTHROCYTE CONCENTRATE; FEMALE; FETUS MONITORING; HUMAN; INTENSIVE CARE UNIT; LUNG EMBOLISM; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; SOLUTIO PLACENTAE; TRACHEOSTOMY; UTERINE ATONY;

ADULT; BRONCHIAL SPASM; CARBOPROST; COAGULANTS; CRITICAL ILLNESS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 33846941507     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01227.x     Document Type: Article

References (14)

1. Pharmacia & Upjohn Company. Hemabate® (Carboprost Tromethamine Injection) Product Information Leaflet. PL 0814350311. Pharmacia & Upjohn Company, 2002 [www.pfizer.com]. Accessed 19 December 2006.
2. BMJ Publishing Group Ltd. British National Formulary. London: Royal Pharmaceutical Society of Great Britain and the British Medical Association, 2005.
3. Mrvos R, Kerr FJ, Krenzelok EP. Carboprost exposure in a newborn with recovery. J Toxicol Clin Toxicol 1999;37:865-86.
4. Hayashi RH, Castillo MS, Noah ML. Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F2 alpha. Obstet Gynecol 1981;58:426-9.
5. Hayashi RH, Castillo MS, Noah ML. Management of severe post partum hemorrhage with a prostaglandin F2 alpha analogue. Obstet Gynecol 1984;63:806-8.
6. Buttino L, Garite TJ. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage. Am J Perinatol 1986;3:241-3.
7. Lucas DN, Yentis SM, Kinsella SM, Holdcroft A, May AE, Wee M, et al. Urgency of caesarean section: a new classification. J R Soc Med 2000;93:346-50.
8. Wallace N, Hill D. Major obstetric haemorrhage. CPD Anaesthesia 2003;5:62-6.
9. Lewis G, Drife J. Why Mothers Die 1997-1999. The Confidential Enquiries into Maternal Deaths in the United Kingdom - the fifth report. 2001 [www.cemach.org.uk/publications/CEMDreports/cemdrpt.pdf]. Accessed 7 December 2005.
10. Chou MM, MacKenzie IZ. A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F sub 2alpha, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section. Am J Obstet Gynecol 1994;171:1356-60.
11. Pinder AJ, Dresner M, Calow C, O'Riordan J, Johnson R. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth 2002;11:156-9.
12. Cooley DM, Glosten B, Roberts JR, Eppes PD, Barnes RB. Bronchospasm after intramuscular 15-methyl prostaglandin F2 alpha and endotracheal intubation in a nonasthmatic patient. Anesth Analg 1991;73:87-9.
13. Lamont RF, Morgan DJ, Logue M, Gordon H. A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage. Prostaglandins Other Lipid Mediat 2001;66:203-10.
14. The Cochrane Collaboration. The Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd. 2006 [www.cochrane.org/reviews/en/ab003249.html]. Accessed 27 September 2006.